⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for filanesib

Every month we try and update this database with for filanesib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaNCT01372540
Plasma Cell Leu...
Recurrent Plasm...
Refractory Plas...
Carfilzomib
Filanesib
Laboratory Biom...
18 Years - M.D. Anderson Cancer Center
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) PatientsNCT02384083
Multiple Myelom...
Filanesib, poma...
18 Years - PETHEMA Foundation
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) PatientsNCT02384083
Multiple Myelom...
Filanesib, poma...
18 Years - PETHEMA Foundation
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaNCT01372540
Plasma Cell Leu...
Recurrent Plasm...
Refractory Plas...
Carfilzomib
Filanesib
Laboratory Biom...
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: